Müller Cornelia Sigrid Lissi
MVZ für Histologie, Zytologie und molekulare Diagnostik Trier GmbH, Max-Planck-Str. 5, 54296, Trier, Deutschland.
Medizinische Fakultät, Universität des Saarlandes, Kirrberger Str. 100, 66421, Homburg/Saar, Deutschland.
Dermatologie (Heidelb). 2024 Dec;75(12):947-966. doi: 10.1007/s00105-024-05424-6. Epub 2024 Nov 25.
Immunohistochemical examinations have been used for many years in dermatopathology and pathology and have become an integral part of tumor diagnostics. The aim is to identify and classify tumor cells that express distinct antigens. Malignant melanoma can be characterized by a large number of well-described and standardized antibodies, so that immunohistochemical staining is used in the diagnosis of melanoma, the differential diagnosis of other tumors, the determination of tumor thickness, the diagnosis of tumor metastases, and also in the diagnosis of sentinel lymph nodes. Comprehensive knowledge of the expression profiles and specific staining patterns of the antibodies used is of great diagnostic relevance, with the aim of preventing misdiagnosis. The perfect antibody with high sensitivity and maximum specificity does not exist. Hence, immunohistochemistry does not replace the conventional assessment and interpretation of tumor samples. Only in symbiosis with clinical and conventional histological findings do immunohistochemical stains have a diagnostic value.
免疫组织化学检查在皮肤病理学和病理学中已应用多年,并且已成为肿瘤诊断不可或缺的一部分。其目的是识别和分类表达不同抗原的肿瘤细胞。恶性黑色素瘤可用大量描述详尽且标准化的抗体进行特征性分析,因此免疫组织化学染色用于黑色素瘤的诊断、其他肿瘤的鉴别诊断、肿瘤厚度的测定、肿瘤转移的诊断以及前哨淋巴结的诊断。全面了解所用抗体的表达谱和特异性染色模式具有重要的诊断意义,目的是防止误诊。不存在具有高灵敏度和最大特异性的完美抗体。因此,免疫组织化学不能取代对肿瘤样本的传统评估和解读。只有与临床和传统组织学检查结果相结合,免疫组织化学染色才有诊断价值。